Cargando…

Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer

OBJECTIVE: The primary goal of this study was to determine the difference of abundance of CD4+, CD8+ and CD56+ bronchoalveolar fluid’s lymphocytes and their subpopulations between cancerous lung and healthy lung from the same patient. METHODS: Mini-bronchoalveolar lavage was taken from 55 patients f...

Descripción completa

Detalles Bibliográficos
Autores principales: Jusufovic, Edin, Prnjavorac, Besim, Iljazovic, Ermina, Kosnik, Mitja, Keser, Dragan, Korosec, Peter, Stahov, Jugoslav, Zukic, Edin, Sejdinovic, Rifat, Ajanovic, Ekrem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570940/
https://www.ncbi.nlm.nih.gov/pubmed/23408789
http://dx.doi.org/10.5455/aim.2011.19.132-137
_version_ 1782259127338139648
author Jusufovic, Edin
Prnjavorac, Besim
Iljazovic, Ermina
Kosnik, Mitja
Keser, Dragan
Korosec, Peter
Stahov, Jugoslav
Zukic, Edin
Sejdinovic, Rifat
Ajanovic, Ekrem
author_facet Jusufovic, Edin
Prnjavorac, Besim
Iljazovic, Ermina
Kosnik, Mitja
Keser, Dragan
Korosec, Peter
Stahov, Jugoslav
Zukic, Edin
Sejdinovic, Rifat
Ajanovic, Ekrem
author_sort Jusufovic, Edin
collection PubMed
description OBJECTIVE: The primary goal of this study was to determine the difference of abundance of CD4+, CD8+ and CD56+ bronchoalveolar fluid’s lymphocytes and their subpopulations between cancerous lung and healthy lung from the same patient. METHODS: Mini-bronchoalveolar lavage was taken from 55 patients from lung with cancer and healthy lung. After laboratory processing and addition of CD4, CD8, CD27, CD28 and CD56 antibody, the material was analyzed by flow cytometer. Results from lung with cancer were compared to the ones from the healthy lung. The examined patients were the test and the control group at the same time. RESULTS: CD27+28+ forms of CD4+ and CD8+ lymphocytes are more activated in the cancerous lung compared to healthy lung, while the CD27-28- forms are less activated in diseased lung. CD4+ forms of CD56+ lymphocytes are more activated in cancerous lung compared to the health lung, while the CD8+ forms are less activated in diseased lung. CONCLUSION: Immature helper and cytotoxic T lymphocyte response, as well as regulatory NK and NKT cell response are more activated in cancerous lung compared to the health lung of the same patient.
format Online
Article
Text
id pubmed-3570940
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher AVICENA, d.o.o., Sarajevo
record_format MEDLINE/PubMed
spelling pubmed-35709402013-02-13 Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer Jusufovic, Edin Prnjavorac, Besim Iljazovic, Ermina Kosnik, Mitja Keser, Dragan Korosec, Peter Stahov, Jugoslav Zukic, Edin Sejdinovic, Rifat Ajanovic, Ekrem Acta Inform Med Article OBJECTIVE: The primary goal of this study was to determine the difference of abundance of CD4+, CD8+ and CD56+ bronchoalveolar fluid’s lymphocytes and their subpopulations between cancerous lung and healthy lung from the same patient. METHODS: Mini-bronchoalveolar lavage was taken from 55 patients from lung with cancer and healthy lung. After laboratory processing and addition of CD4, CD8, CD27, CD28 and CD56 antibody, the material was analyzed by flow cytometer. Results from lung with cancer were compared to the ones from the healthy lung. The examined patients were the test and the control group at the same time. RESULTS: CD27+28+ forms of CD4+ and CD8+ lymphocytes are more activated in the cancerous lung compared to healthy lung, while the CD27-28- forms are less activated in diseased lung. CD4+ forms of CD56+ lymphocytes are more activated in cancerous lung compared to the health lung, while the CD8+ forms are less activated in diseased lung. CONCLUSION: Immature helper and cytotoxic T lymphocyte response, as well as regulatory NK and NKT cell response are more activated in cancerous lung compared to the health lung of the same patient. AVICENA, d.o.o., Sarajevo 2011-09 /pmc/articles/PMC3570940/ /pubmed/23408789 http://dx.doi.org/10.5455/aim.2011.19.132-137 Text en © 2011 AVICENA http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Jusufovic, Edin
Prnjavorac, Besim
Iljazovic, Ermina
Kosnik, Mitja
Keser, Dragan
Korosec, Peter
Stahov, Jugoslav
Zukic, Edin
Sejdinovic, Rifat
Ajanovic, Ekrem
Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer
title Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer
title_full Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer
title_fullStr Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer
title_full_unstemmed Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer
title_short Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer
title_sort local cd4+, cd8+ and cd56+ t-lymphocite reaction on primary lung cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570940/
https://www.ncbi.nlm.nih.gov/pubmed/23408789
http://dx.doi.org/10.5455/aim.2011.19.132-137
work_keys_str_mv AT jusufovicedin localcd4cd8andcd56tlymphocitereactiononprimarylungcancer
AT prnjavoracbesim localcd4cd8andcd56tlymphocitereactiononprimarylungcancer
AT iljazovicermina localcd4cd8andcd56tlymphocitereactiononprimarylungcancer
AT kosnikmitja localcd4cd8andcd56tlymphocitereactiononprimarylungcancer
AT keserdragan localcd4cd8andcd56tlymphocitereactiononprimarylungcancer
AT korosecpeter localcd4cd8andcd56tlymphocitereactiononprimarylungcancer
AT stahovjugoslav localcd4cd8andcd56tlymphocitereactiononprimarylungcancer
AT zukicedin localcd4cd8andcd56tlymphocitereactiononprimarylungcancer
AT sejdinovicrifat localcd4cd8andcd56tlymphocitereactiononprimarylungcancer
AT ajanovicekrem localcd4cd8andcd56tlymphocitereactiononprimarylungcancer